ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
GlaxoSmithKline AG - Bexsero, Injektionssuspension
6573001
BexseroInjektionssuspension
J07AH09Meningococcus B, Multicomponent Vaccine
23.11.2017  
Composition
proteinum fusionatum NHBA neisseriae meningitidis B 50 µg, proteinum NadA neisseriae meningitidis B 50 µg, proteinum fusionatum fHbp neisseriae meningitidis B 50 µg, vesicula membranae exterioris (OMV) ex Neisseria meningitidis B (Stamm: NZ98/254) 25 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, histidinum, natrii chloridum, saccharum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.2 mg.
Packungsbestandteile
Injection suspension 
  
 
Active AgentDose
Proteinum Fusionatum fhbp Neisseriae Meningitidis B50µg / 0.5ml
Proteinum Fusionatum nhba Neisseriae Meningitidis B50µg / 0.5ml
Proteinum nada Neisseriae Meningitidis B50µg / 0.5ml
Vesicula Membranae Exterioris (Omv) ex Neisseria Meningitidis b (Stamm: Nz98/254)25µg / 0.5ml
BAG: Active AgentDose
Neisseria Meningitidis b Outer Membrane Vesicle25 mcg
Proteinum Fusionatum fhbp Neisserii Meningitidii B50 mcg
Proteinum Fusionatum nhba Neisserii Meningitidii B50 mcg
Proteinum nada Neisserii Meningitidii B50 mcg
 
Inactive agentsDose
Alumine0.5mg / 0.5ml
Histidine 
Sodium Chloride 
Saccharum 
 
Package numberPackage SizeEFPCPCategorySLOut of trade (MedRef)
003 78.14101.40BSLNo
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home